Bill
HB 1109
Hawaii HB 1109 establishes regulatory standards for manufactured hemp products to ensure safety, quality, and accurate labeling of cannabinoid derivatives sold to consumers.
HB 1109 regulates the manufacturing, labeling, and sale of hemp-derived products in Hawaii. The bill establishes standards for manufactured hemp products (likely including cannabinoid products like delta-8, delta-10, and other synthetic or concentrated hemp derivatives) to ensure consumer safety and product quality control.
As hemp-derived cannabinoid products proliferate in legal gray areas nationwide, Hawaii is attempting to create a regulatory framework to protect consumers from unlabeled potency, contamination, and misleading marketing. This addresses a real gap where these products often bypass traditional cannabis licensing requirements while remaining widely available.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
